Breast cancer is the most prevalent cancer in women worldwide. Roche has been leading research into breast cancer for decades and remains committed to discovering new treatments that can improve the lives of patients and their families.
Learn more about latest advances in breast cancer research by Roche Oncology.
Nov 09 2017 | Breast CancerThe high prevalence of breast cancer in the global population necessitates a need for early identification and treatment.
Jun 05 2018 | Breast Cancer ASCO 2018
ASCO 2018 oral presentation- Phase III study of taselisib (GDC-0032) + fulvestrant (FULV) v FULV in patients (pts) with estrogen receptor (ER)-positive, PIK3CA-mutant (MUT), locally advanced or metastatic breast cancer (MBC): Primary analysis from SANDPIPER